Add BrightSurf on Google Email

WashU Medicine


New genetic clues to early-onset form of dementia

Researchers have identified a single mutation in the MAPT gene as the culprit behind inherited frontotemporal dementia, leading to impaired communication between brain neurons and neurodegeneration. The study offers new potential treatment targets for both this condition and Alzheimer's disease.

SourceWashU Medicine·JournalTranslational Psychiatry·DateDec 13, 2018

Regrowing damaged nerves hinges on shutting down key genes

Researchers identified a suite of genes that must be turned off for axons to regenerate in peripheral nerves after injury. To regrow, neurons must transition back to an immature state and re-engage developmental programs. The study provides evidence for the idea that cells must become less mature to regenerate.

SourceWashU Medicine·JournalProceedings of the National Academy of Sciences·DateDec 10, 2018

MRI scans shows promise in predicting dementia

Researchers used diffusion tensor imaging to assess white matter health and found that individuals who went on to experience cognitive decline had significantly more signs of damage. The study predicted cognitive decline with 89% accuracy, rising to 95% when focusing on specific brain areas.

Cardiovascular disease, Alzheimer's genetically linked

Researchers identified 90 genetic points associated with increased risk for both cardiovascular disease and Alzheimer's, including genes involved in lipid metabolism. The study found that targeting these genes may help lower Alzheimer's risk by managing cholesterol and triglyceride levels.

SourceWashU Medicine·JournalActa Neuropathologica·DateNov 11, 2018

Link between autoimmune, heart disease explained in mice

Studies in mice with psoriasis-like conditions found that stiff blood vessel walls trapped cholesterol, promoting plaques and increasing cardiovascular risk. Neutralizing a specific immune cell type reduced collagen density and cholesterol deposits, suggesting a preventable link between autoimmune diseases and heart disease.

SourceWashU Medicine·JournalCell Metabolism·DateNov 8, 2018

Relapsed leukemia flies under immune system's radar

Researchers found that relapsed leukemia cells have reduced expression of genes involved in immune recognition, making them invisible to the immune system. Interferon gamma has been shown to turn back on these hidden immune markers, suggesting a potential therapeutic approach for AML patients who relapse after transplantation.

SourceWashU Medicine·JournalNew England Journal of Medicine·DateOct 31, 2018

Scoliosis linked to essential mineral

A new study links scoliosis to the body's inability to utilize the essential dietary mineral manganese. Children with severe scoliosis are twice as likely to carry a gene variant that makes it hard for their cells to take in and use manganese, which is required for growing bones and cartilage.

SourceWashU Medicine·JournalNature Communications·DateOct 9, 2018

Viruses in blood lead to digestive problems

Researchers found that viruses like West Nile and Zika can kill neurons in the gut, disrupting bowel movement and causing intestinal blockages. The study provides clues to sudden onset of digestive woes and potentially points to a new strategy for preventing such conditions.

SourceWashU Medicine·JournalCell·DateOct 4, 2018

Even light drinking increases risk of death

A new study from Washington University School of Medicine found that consuming one to two drinks four or more times per week increases the risk of premature death by 20%, compared to drinking three times a week or less. This increased risk was consistent across age groups and outweighed potential benefits in cardiovascular health.

Study IDs why some TB bacteria prove deadly

Researchers found that a single mutation in TB bacteria makes them resistant to antibiotics and elicits a weaker immune response, leading to higher mortality rates. The study suggests that the same approach may not work for drug-resistant TB strains.

SourceWashU Medicine·JournalNature Microbiology·DateSep 17, 2018

Scientists identify weak point in deadly eye melanoma

A natural plant compound called FR900359 has been identified as a potential treatment for uveal melanoma, shutting down the overactive signaling that drives cell growth. The compound traps G alpha q in its inactive state, preventing tumor cell growth and potentially reversing cancer-like changes.

SourceWashU Medicine·JournalScience Signaling·DateSep 5, 2018

New clues found to understanding relapse in breast cancer

A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes. The study identified three genes - DDR1, PIK3R1 and NF1 - with relatively uncommon mutations that were associated with cancer recurrence and spreading.

SourceWashU Medicine·JournalNature Communications·DateSep 4, 2018

Alzheimer's one day may be predicted during eye exam

Scientists have detected signs of Alzheimer's disease in the eyes of patients who showed no symptoms, using a non-invasive technique called optical coherence tomography angiography. The study found that patients with elevated levels of Alzheimer's proteins had significant thinning in the center of their retinas.

SourceWashU Medicine·JournalJAMA Ophthalmology·DateAug 23, 2018

Lowering hospitals' Medicare costs proves difficult

A new study found that a bundled-payment system did not lower Medicare costs for patients hospitalized for serious medical conditions. Despite providing financial incentives, hospitals saw no significant reductions in costs, with average costs remaining largely unchanged.

SourceWashU Medicine·JournalNew England Journal of Medicine·DateJul 18, 2018

New ALS therapy in clinical trials

Researchers have developed a new ALS therapy that extends survival and reverses signs of neuromuscular damage in mice and rats with SOD1 mutations. The investigational drug, an antisense oligonucleotide, has shown impressive effects in preclinical trials.

SourceWashU Medicine·JournalJournal of Clinical Investigation·DateJul 16, 2018

Can fasting improve MS symptoms?

Researchers are testing whether drastically cutting calories twice a week can change MS symptoms. A study found that intermittent fasting reduced MS-like symptoms in mice, with changes in immune cells and gut microbiome.

SourceWashU Medicine·JournalCell Metabolism·DateJul 9, 2018

Parent-child therapy helps young children with depression

A new study from WashU Medicine demonstrates that an interactive Parent-Child Interaction Therapy (PCIT) can reduce depression rates and lower symptom severity in children as young as 3. The therapy program focuses on enhancing emotional development and also improves parent mental health.

SourceWashU Medicine·JournalAmerican Journal of Psychiatry·DateJun 20, 2018

Eczema drug effective against severe asthma

Dupilumab alleviates asthma symptoms and improves lung function in moderate to severe asthma patients. The drug significantly reduced asthma exacerbations by half in some patients, with improved rates of emergency room visits and hospitalizations.

SourceWashU Medicine·JournalNew England Journal of Medicine·DateMay 21, 2018

Blood type affects severity of diarrhea caused by E. coli

A study by Washington University School of Medicine found that people with blood type A are more likely to experience severe diarrhea caused by E. coli. Researchers identified a protein responsible for this blood-group difference, which could lead to the development of a vaccine targeting this protein.

SourceWashU Medicine·JournalJournal of Clinical Investigation·DateMay 17, 2018

Psoriasis treated with compound derived from immune cells

A compound derived from immune cells has been found to treat psoriasis in mice, with the potential to be effective against other autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. The study suggests that the compound suppresses an inflammatory pathway that is overactive in these conditions.

SourceWashU Medicine·JournalNature·DateApr 18, 2018

ALS, rare dementia share genetic link

Researchers have identified genetic links between ALS and frontotemporal dementia, suggesting that treatments for one may also work for the other. The study found common genetic variations associated with both disorders, including those near the MAPT gene and BNIP1.

SourceWashU Medicine·JournalJAMA Neurology·DateApr 9, 2018

Macular degeneration linked to aging immune cells

Research at Washington University School of Medicine found that aging immune cells contribute to inflammation and abnormal blood vessel growth in macular degeneration, potentially leading to vision loss. The study identified microRNA-150 as a potential therapeutic target for preventing progression to advanced forms of the disease.

SourceWashU Medicine·JournalJCI Insight·DateApr 5, 2018